网站标志
点评详情
发布于:2021-10-10 18:44:50  访问:52 次 回复:0 篇
版主管理 | 推荐 | 删除 | 删除并扣分
Chbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction
Hazard elements for high CS-4343 erythropoiesis stimulating agent resistance index in pre-dialysis long-term kidney disorder sufferers, phases four and 5. Locatelli F, Andrulli S, Memoli B, Maffei C, Del Vecchio L, 1454846-35-5 chemical information Aterini S, et al. Nutritional-inflammation position and resistance to erythropoietin remedy in haemodialysis patients. Nephrol Dial Transplant. 2006;21(four):991?. 11. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase reaction predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999;33(1):sixty three?2. 12. Costa E, Lima M, Alves JM, Rocha S, Rocha-Pereira P, Castro E, et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic22.23.24.twenty five.26.27.28.29.thirty.31.32.kidney disease clients less than hemodialysis and its relationship to resistance to recombinant human erythropoietin remedy. J Clin Immunol. 2008;28(3):268?five. Pajek J, Bucar-Pajek M, Grego K, Gucek A, Bevc S, Ekart R, et al. Epoetin responsiveness in peritoneal dialysis sufferers: a multi-center Slovenian analyze. Ther Apher Dial. 2005;nine(3):228?two. Szczech LA, Barnhart HX, Inrig JK, Reddan DN, Sapp S, Califf RM, et al. Secondary evaluation with the CHOIR trial epoetin-alpha dose and realized hemoglobin results.Chbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction with the anemia of end-stage renal illness with recombinant human erythropoietin. Results of the blended period I and II medical demo. N Engl J Med. 1987;316(two):73?. 2. Messana JM, Chuang CC, Turenne M, Wheeler J, Turner J, Sleeman K, et al. Association of quarterly average accomplished hematocrit with mortality in dialysis individuals: a time-dependent comorbidity-adjusted design. Am J Kidney Dis. 2009;fifty three(three):503?two. 3. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM. The effects of upper hemoglobin stages on mortality and hospitalization in hemodialysis sufferers. Kidney Int. 2003;sixty three(5):1908?four. four. Macdougall IC, Tomson CR, Steenkamp M, Ansell D. Relative risk of loss of life in British isles haemodialysis sufferers in relation to accomplished haemoglobin from 1999 to 2005: an observational review using Uk Renal Registry facts incorporating 30,040 patient-years of follow-up. Nephrol Dial Transplant. 2010;twenty five(3):914?. 5. de Lurdes Agostinho Cabrita A, Pinho A, Malho A, Morgado E, Faisca M, Carrasqueira H, et PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/7891282 al. Hazard aspects for top erythropoiesis stimulating agent resistance index in pre-dialysis continual kidney sickness 4871-97-0 web people, stages four and 5. Int Urol Nephrol. 2011;43(three):835?0. 6. Di Iorio BR, Stellato D, De Santo NG, Cirillo M. Affiliation of gender and age with erythropoietin resistance in hemodialysis clients: function of menstrual position. Blood Purif. 2004;22(5):423?. seven. Lopez-Gomez JM, Portoles JM, Aljama P. Variables that condition the response to erythropoietin in clients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008;111:S75?1. 8. Mallick S, Rafiroiu A, Kanthety R, Iqbal S, Malik R, Rahman M. Elements predicting erythropoietin resistance between routine maintenance hemodialysis people. Blood Purif. 2012;33(four):238?4. 9. Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K, Soma M.
共0篇回复 每页10篇 页次:1/1
共0篇回复 每页10篇 页次:1/1
我要回复
回复内容
验 证 码
看不清?更换一张
匿名发表 
脚注信息
版权所有 Copyright(C)2009-2016 鞋类商城成品网站演示